| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $60.8B | $70.4B | $15.1B | $60.0B | $70.9B | $16.0B | $19.2B | $18.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $3.6B | $2.7B | $1.3B | $-1.4B | $7.7B | $0.8B | $1.1B | $0.8B |
| EPS (Basic) | $10.05 | $7.54 | $3.62 | $-3.93 | $19.65 | $2.04 | $2.78 | $2.01 |
| EPS (Diluted) | $9.99 | $7.50 | $3.61 | $-3.93 | $19.51 | $2.03 | $2.76 | $1.99 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $773.7B | $735.6B | $721.1B | $689.9B | $937.6B | $940.7B | $896.6B | $815.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $19.7B | $18.5B | $19.4B | $17.3B | $12.9B | $13.7B | $16.3B | $15.4B |
| Total Liabilities | $738.2B | $705.5B | $691.3B | $672.7B | $875.0B | $872.5B | $832.8B | $766.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $32.4B | $27.9B | $27.8B | $16.3B | $61.9B | $67.4B | $63.1B | $48.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.3B | $8.5B | $6.5B | $5.2B | $9.8B | $8.4B | $19.6B | $21.7B |
| Investing Cash Flow | $-25.9B | $-28.6B | $-12.1B | $-7.6B | $-5.3B | $-16.2B | $-17.0B | $-21.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $20.8B | $19.4B | $7.7B | $4.9B | $-3.0B | $4.9B | $-1.6B | $0.8B |